Loading...
Among the various proposed benefits of structured treatment interruption (STI), one of the more intriguing is that it would provide an effective way to manage patients with drug-resistant virus. Under this hypothesis, cessation of drug therapy would lead to emergence of wild-type virus, allowing for initiation of an effective salvage regimen. In this prospective randomized trial, a strategy of 16 weeks of STI before starting salvage therapy was compared with immediate initiation of a salvage regimen in patients with multidrug-resistant virus.
Patients were enrolled from 16 sites throughout the U.S. that participate in the government-funded Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Eligibility criteria included a v…